SINTX Technologies

SINTX Technologies P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of SINTX Technologies (SINT) as of Oct 26, 2026 is -1.33. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -1.25 — a change of 6.53% (lower).

P/FCF

-1.33

YoY

6.53%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of SINTX Technologies is 2025 -1.33 . P/FCF (Price-to-Free-Cash-Flow Ratio) of SINTX Technologies was 2024 -1.25 . It decreases by 6.53% lower compared to the previous year.

The SINTX Technologies P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
-1.24 USD
Jan 1, 2019
-1.78 USD
Jan 1, 2020
-1.23 USD
Jan 1, 2021
-0.84 USD
Jan 1, 2022
-1.00 USD
Jan 1, 2023
-0.80 USD
Jan 1, 2024
-1.25 USD
Jan 1, 2025
-1.33 USD
The SINTX Technologies P/FCF history
YEARP/FCFYoY
-1.33+6.53%
-1.25+56.93%
-0.80-20.33%
-1.00+18.88%
-0.84-31.71%
-1.23-30.51%
-1.78+42.95%
-1.24-37.66%
-1.99+33.67%
-1.49+24.45%
-1.20+71.08%
-0.70—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SINTX Technologies Stock analysis

What does SINTX Technologies do? SINTX Technologies, Inc. generates revenue by manufacturing and selling silicon nitride-based orthopedic medical devices. The company focuses on vertically integrated production of silicon nitride ceramic technology for hip and knee arthroplasty components, including solid, porous, composite, and coated forms. Its primary customers are surgeons and hospitals in the United States, Europe, and South America, who purchase these wear- and corrosion-resistant implant components for total hip and knee replacement procedures. The firm markets its products directly to healthcare providers through its established distribution channels in target markets. The company's revenue stream is derived from the sale of silicon nitride ceramic technology platforms used in medical devices, with a specific emphasis on orthopedic applications. By developing and producing implant components that incorporate silicon nitride, SINTX addresses the need for durable, high-performance materials in joint replacement surgeries. This approach allows the company to target the growing market for advanced orthopedic solutions in key regions. SINTX Technologies, Inc. operates as a commercial biomaterial company specializing in silicon nitride ceramic technology. Its product portfolio includes components for total hip and knee replacement systems, which are sold to healthcare institutions globally. The firm's vertically integrated manufacturing model ensures control over the production of silicon nitride materials, enabling consistent quality and innovation in its medical device offerings. SINTX Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SINTX Technologies stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of SINTX Technologies is -1.33 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of SINTX Technologies changed from -1.25 to -1.33, representing a 6.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) SINTX Technologies since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s SINTX Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — SINTX Technologies

All Key Metrics — SINTX Technologies